Abstract:PURPOSE: To explore the expression of stem cell genes in breast cancer and the relationship between stem cell gene expression and clinical and pathological characteristics and prognosis of breast cancer.BACKGROUND: By now, stem cell differentiation-related genes and the relationship between the genes and clinic-pathological characteristics and prognosis of breast cancer are still unclear.MATERIALS AND METHODS: CD44+/CD24- tumor cells were selected by Flow cytometry. The differential expression of genes between CD44+/CD24- tumor cells and non-CD44+/CD24- tumor cells were detected by RT(2) Profiler™ PCR Array. The expression of stem cell gene Octamer-4 (Oct-4) was analyzed by immunohistochemistry staining and the relationship between Oct-4 and clinicopathological parameters of breast cancer was determined.RESULTS: Seven different genes including stem cell differentiation-related factors (CD44, Oct-4, and nestin), cell cycle regulators (APC and CDC2), and growth factors (HGF and TGF) were detected as significantly differently expressed between CD44+/CD24- tumor cells and non-CD44+/CD24- tumor cells. Oct-4 protein expressed significantly higher in cancerous tissues than adjacent-tumor tissues (P = 0.001). Moreover, we observed that the expression of Oct-4 protein was related to histological type, lymph node status and molecular type of breast cancer (P = 0.001, 0.006, and 0.001, respectively). After survival analysis, the cases with highly expressed Oct-4 protein attained a significantly poorer postoperative disease-specific survival than those with none/low expressed Oct-4 protein (P = 0.001). In the Cox regression test, tumor size, histological type, disease stage, lymph node metastasis, Her-2 and Oct-4 were detected as the independent prognostic factors (P = 0.031, 0.012, 0.001, 0.002, 0.030, and 0.003, respectively).CONCLUSIONS: Oct-4 was highly expressed in CD44+/CD24- tumor cells, and may be a potential biomarker for the initiation, progression, and differentiation of breast cancer.

Expression of OCT-4 in Lung Cancer and Its Clinical Significance

Oct-4 Expression in Epidermal Tumors

Expression of Octamer-4 in Serous and Mucinous Ovarian Carcinoma.

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Expression of Oct-4 in gastric carcinoma and its clinical significance

Clinical Implications of Stem Cell Gene Oct-4 Expression in Breast Cancer

The Expression of Stem Cell-Related Indicators As a Prognostic Factor in Human Lung Adenocarcinoma.

Expression of Embryonic Stem Cell Marker Oct-4 and Its Prognostic Significance in Rectal Adenocarcinoma

Expression of Oct-4 protein in rectal adenocarcinoma and its correlation with prognosis

Atypical expression and distribution of embryonic stem cell marker, OCT4, in human lung adenocarcinoma.

Expression of OCT4 in Human Esophageal Squamous Cell Carcinoma is Significantly Associated with Poorer Prognosis

Oct4, A Novel Marker for Human Gastric Cancer

Implications of Transcriptional Factor, OCT-4, in Human Bladder Malignancy and Tumor Recurrence

Study on significance of expression of Nanog and Oct4 by using tissue chip technique in non small cell lung cancer

Expression of Oct4 Gene in Cervical Cancer

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

Expression and Clinical Significance of Cancer Stem Cell Marker CD133,CD44,SOX2, OCT4 and ALDH1 in Non-small Cell Lung Cancer

OCT4 Expression in Human Non-Small Cell Lung Cancer: Implications for Therapeutic Intervention,,

Profiling of Genes Differentially Expressed After Targeted Inactivation of OCT4 Pluripotent Transcription Factor in Human Lung Adenocarcinoma Stem Cells

Expression of Oct4 Protein in Non-Muscle-invasive Bladder Cancer

Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer